Public trial registry of the CCC-Munich

Trial AFFECT

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AFFECT
World
Full title
:

Gemcitabine and nab-Paclitaxel Combined with the Oral Irreversible ErbB Family Blocker Afatinib in Patients with Metastatic Pancreatic Cancer: a Phase I b Trial

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
KUM - Med3 - Medizinische Klinik und Poliklinik III Lmu
Indications
Classification Code Description
ICD-10-GM C25.0 Pankreaskopf
ICD-10-GM C25.1 Pankreaskörper
ICD-10-GM C25.2 Pankreasschwanz
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
I
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Positive
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Participants The lead of this trial has not explicitely given their approval for publishing the contact information of the principal investigators or specific contact persons.